These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8406154)

  • 1. Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.
    Raab Y; Gerdin B; Ahlstedt S; Hällgren R
    Gut; 1993 Sep; 34(9):1203-6. PubMed ID: 8406154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.
    Carlson M; Raab Y; Sevéus L; Xu S; Hällgren R; Venge P
    Gut; 2002 Apr; 50(4):501-6. PubMed ID: 11889070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
    Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
    Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis.
    Thörn M; Raab Y; Larsson A; Gerdin B; Hällgren R
    Scand J Gastroenterol; 2000 Apr; 35(4):408-12. PubMed ID: 10831265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis.
    Raab Y; Hällgren R; Gerdin B
    Digestion; 1994; 55(1):44-9. PubMed ID: 8112497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.
    Gibson P; Rosella O
    Gut; 1995 Oct; 37(4):536-43. PubMed ID: 7489942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis.
    Anezaki K; Asakura H; Honma T; Ishizuka K; Funakoshi K; Tsukada Y; Narisawa R
    Intern Med; 1998 Mar; 37(3):253-8. PubMed ID: 9617859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis.
    Keates S; Keates AC; Mizoguchi E; Bhan A; Kelly CP
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G75-82. PubMed ID: 9252512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.
    Mahida YR; Ceska M; Effenberger F; Kurlak L; Lindley I; Hawkey CJ
    Clin Sci (Lond); 1992 Mar; 82(3):273-5. PubMed ID: 1312411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
    Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
    Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis.
    Izzo RS; Witkon K; Chen AI; Hadjiyane C; Weinstein MI; Pellecchia C
    Am J Gastroenterol; 1992 Oct; 87(10):1447-52. PubMed ID: 1329495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of Pulvis Fellis Suis extract in mice with ulcerative colitis.
    He J; Liang J; Zhu S; Li J; Zhang Y; Sun W
    J Ethnopharmacol; 2011 Oct; 138(1):53-9. PubMed ID: 21872653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
    Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
    Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.
    Raab Y; Fredens K; Gerdin B; Hällgren R
    Dig Dis Sci; 1998 May; 43(5):1061-70. PubMed ID: 9590423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
    Ishiguro Y
    J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.
    Dotan I; Levy-Nissenbaum E; Chowers Y; Fich A; Israeli E; Adar T; Shteingart S; Soreq H; Goldin E
    Dig Dis Sci; 2016 Nov; 61(11):3246-3254. PubMed ID: 27572942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis.
    Bhaskar L; Ramakrishna BS; Balasubramanian KA
    J Gastroenterol Hepatol; 1995; 10(2):140-3. PubMed ID: 7787158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.